Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

World Hematology 2020

About the Conference

14th World Congress on Hematology and Oncology September 28-29, 2020. The conference is scheduled as an online event/Webinar. This congress is expected to be the largest and best platform for all the scientists, haematologists, oncologists, pathologists, surgeons, nurses, research scholars, business professionals, students who are working in the field of Hematology. 

Theme: Advancements and new outlook in Hematology

Hematology Congress 2020 will include speaker talks, brief keynote presentations, workshops and exhibitions, where researchers and associations will exchange ideas and discuss the methodology for new Diagnostics and treatment methods for Hematologic Disorders, Management and Care of Patients, new approaches emerging in Hematology etc.

".CME Accredited Hematologists 2020 will be organized by ConferenceSeries Ltd which is comprised of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. ConferenceSeries Ltd  through its international conferences provides an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.

Why to attend?

Conferences share lots of knowledge to Universities, companies. It is advantageous to medical students and researchers furthermore for professors and science laboratory technicians. Conferences additionally benefits and share information between scientist, doctors and delegates. One company network with different company and that they share information to each other regarding their product at the conference. The companies return to attend conferences and show their exhibit before of eminent members and delegates present at the Conference.

Target Audience

  • Hematologists
  • Oncologists
  • Haematopathologists
  • Scientists
  • Young Researchers
  • Medical Students
  • Physicians/Consultants/ General Practitioners
  • Nurses
  • Residents
  • Directors/Managers
  • Pathologists
  • Presidents & Vice Presidents/ Directors / Administrators
  • Gynaecologists,
  • Paediatricians specialized in oncology
  • Oncology Professors, Scientists

 

 

Tracks

Track 1: Hematology and Cardio-Oncology

Cardiovascular problems vis-à-vis blood and the immune system that provides laboratory values regarding blood, the cardiovascular system and secures cardiovascular diseases from the Chinese medicine and western medicine perspectives.

Cardio-Oncology is to find a balance between oncologic efficacy and reducing antagonistic cardiovascular effects over timely publication and broadcasting of research. Cardiac imaging and transthoracic echocardiography play a crucial role in the baseline assessment and serial follow-up of cardio-oncology patients. Scientific indication in the administration of cardiovascular hitches of onco-hematological patients is unusual, as these patients have been systematically omitted from clinical trials and up-to-date approvals are based on expert consent. Cardio-onco-hematology which allow its claim in regular clinical preparation so to promote the expansion of local multidisciplinary crews, to rally the cardiovascular health of patients with cancer.

  • Cardiovascular problems
  • Immune system
  • medicine perspectives

Track 2: Vascular Bleeding Disorders

Haemorrhage disorders are instigated by vascular malformation or impairment. They are linked with cutaneous or mucosal flat or palpable purpura. These disorders are a heterogeneous assembly of circumstances categorized by easy staining, petechiae, mucosal bleeding, ecchymosis and impulsive bleeding from small vessels. The fundamental imperfection is stated to be moreover in the vessels themselves or in the perivascular connective tissue.

Worth mentioning, the commonly used “purpura” is generally describe subcutaneous bleeding, that may be linked to blood vessel wall abnormalities (described here) or platelet abnormalities. Of which some are hereditary and while the others are acquired.

  • Vascular Bleeding
  • Purpura

Track 3: Clinical Hematology

Hematology refers to the study of the numbers and morphology of the cellular elements of the blood—the RBCs (erythrocytes), WBCs (leukocytes), and platelets (thrombocytes)—and the use of these results in the diagnosis and monitoring of disease

If your primary care physician has suggested that you see a hematologist, it may be because you are at risk for a condition involving your red or white blood cells, bone marrow, blood vessels, lymph nodes, or spleen. platelets,

Some of these conditions are:
hemophilia, a disease that prevents your blood from

 

Track 4: Neuro-hematology

The crossing point amongst hematology and neurology is comprehensive, and neurological complications in the course of hematologic ailment are recurrent and diverse. Polycythemia, in which there are increased numbers of red blood cells with iron deficient. Polycythemia and the comparative Sideropenia lead to amplified blood viscosity with connected neurological symptoms and signs.

Haematological conditions that lead into neurological manifestations are Thrombophilia, antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, sickle cell, myeloma, leukemias, lymphomas and clonal disorders. These are considered into benign and malignant situations.

  • Neurology
  • Lymphomas

Track 5: Transfusion Medicines

Blood Transfusion is a medical practice where donated blood is transfused to a recipient. It is a lifesaving, benign procedure. These are used to treat several medical conditions such as iron deficiency Anemia, Sickle cell ailment, severe haemorrhage generally from surgery, childbirth or a serious fate. What's more whole blood or blood components (red blood cells, white blood cells, plasma and clotting factors) are castoff depending on the state of the patient.

For the reason that high-end medical involvements, the demand for blood and blood components is increasing steadily all over the world. The mandate for blood is progressively growing even though some branches of medicine have brought down its inevitability.  There will be reform of blood transfusion facilities for healthier effectiveness and service delivery. The number of blood banks will drop, and high-volume, technically up-clambered central blood banks will function in their place to diminish the costs of procedure. All together, we predict good scenarios for transfusion medicine specialists by the year 2025, at best in the developing countries. Transfusion medicine has good prospective R&D approaches in Stem Cell Research

  • Blood Transfusion
  • Haemorrhage

Track 6: Hematology Nursing

Hematology medical attendants are the specialists in taking care of the patients with blood related infections. They know about patients' medical history, and they will help the hematologist to analyse and treat the blood related illnesses. The most imperative thing is to teach the patients to deal with the illnesses gallantly.

They can recommend the prescription as they know about the state of the condition. They conceivably spread their assistance in the transplantation of the blood as well. Keeping in mind the end goal to seek after the learning of hematology nursing, one must finish the recognition in nursing or four year college education in nursing and the massive feeling of certainty happens when they have the involvement in the particular field. Hematology nursing is  commonly identified with the hematology oncology.

  • Blood related infections
  • Hematology oncology

Track 7: Case Reports in Hematology

A case report is usually considered a kind of anecdotal proof. Given their intrinsic method limitations, including absence of statistical sampling, case reports are placed at the foot of the hierarchy of clinical proof, beside case series. However, Hematology case reports do have genuinely helpful roles in medical research and evidence-based drugs. Specifically, they need facilitated recognition of recent diseases and adverse effects of treatments. For instance, recognition of the link between administration of teratogen to mothers and malformations in their babies was suggested by the report of a specific case. Case reports have a task in pharmacovigilance. They will additionally facilitate understand the clinical spectrum of rare diseases, moreover as uncommon presentations of common diseases. They can facilitate generate study hypotheses, as well as plausible mechanisms of disease. Case reports might also have a task to play in guiding the personalization of treatments in clinical follow. Therefore it's important to incorporate case reports in Hematologists conferences

  • Hematology case reports
  • Clinical Spectrum

Track 8: Cancer Epidemiology

Cancer Epidemiology represents the study of factors responsible for the initiation, metastasis and prognosis of various types of cancer. Epidemiological research findings on cancer can facilitate the formulation of suitable therapeutic treatment methods and preventive medicines for cancer. When cancer is diagnosed, staging tests help determine how extensive the cancer is in terms of its location, size, growth into nearby structures, and spread to other parts of the body.

Three types of epidemiologic research apply to the field of cancer. Descriptive epidemiology focuses on the trends and frequency of disease in a given population. Analytic epidemiology deals with identifying causes and the predisposing risk associated with the development of disease. Clinical epidemiology outlines screening programs and evaluates the impact of prevention strategies on overall outcome. Environmental carcinogens are ubiquitous but often avoidable if aware.

  • Diagnosis & Staging
  • Tests & Procedures
  • Cancer Prevention & Control

Track 9: Cancer: Lifestyle and Nutrition

A cancer diagnosis is often linked to family medical history, lifestyle choices, or something in the environment. And while you can’t control your family history or your whole environment, healthy lifestyle habits such as a good diet, regular physical activity, weight control, and quitting smoking if you’re prone to lighting up are all within your control.

“Risk factors are individualized, but it’s important to know that there are things you can do to lower your risk”. Sometimes it comes down to the simple things, like reapplying sunscreen to prevent skin cancer if you’ve been outside for a while. Knowing what you're up against can help you devise a plan for what screenings you may need to get (and when), what dietary changes could benefit you, and more — all personalized for you. “Modifying one thing might be helpful for one person but not necessarily helpful for someone else”.

Some of the cancers that most often affect women are breast, colon, endometrial, lung, and cervical, skin, and ovarian cancers. Knowing about these cancers and what you can do to help prevent them or find them early (when they are small and easier to treat) may help save life. Most women with breast cancer will have surgery. The type of surgery you have depends mainly on the size and location of the tumour, the size of the breast.

  • Breast Oncology
  • Breast Implants

Track 10: Cancer Therapy

Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain. Therapies employing stem cells are showing increasing promise in the treatment of cancer. Precision medicine is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. This may also be called personalized medicine.

  •  Surgery
  • Radiation Therapy

Track 11: Types of Surgery for Cancer Treatment

Several types of surgery are helpful to people with cancer. Some surgeries are used in combination with other types of treatment. Curative surgical operations are conducted to remove or destroy cancerous tissue. In a preventive surgery, the surgeon removes tissue that does not yet contain cancer cells, but has the probability of becoming cancerous in the future. The major role of surgery in the diagnosis of cancer lies in the acquisition of tissue for exact histologic diagnosis. Debulking is the reduction of as much of the bulk (volume) of a tumour as possible. It is usually achieved by surgical removal. Surgery to relieve distressing symptoms in an individual with no hope of cure or intent to lengthen their lifespan is considered palliative. Supportive surgery helps make other cancer treatments work effectively. Restorative or reconstructive surgery restores the body’s appearance, or the function of an organ or body part, after major surgery, such as a breast reconstruction after a mastectomy.

  • Preventive surgery
  • Curative surgery

Track 12: Oropharyngeal Cancer

Oropharyngeal cancer is a type of head and neck cancer. Sometimes more than one cancer can occur in the oropharynx and in other parts of the oral cavity, nose, pharynx, larynx(voice box), trachea, or oesophagus at the same time.

Most oropharyngeal cancers are squamous cell carcinomas. Squamous cells are the thin, flat cells that line the inside of the oropharynx.

 

  • Risk Factors
  • Diagnosis & Evaluation

Track 13Thyroid Cancer

Thyroid cancer develops when cells change or mutate. The abnormal cells begin multiplying in thyroid and, once there are enough of them, they form a tumor. Thyroid cancer is more common in women than men. Women tend to get thyroid cancer in their 40s and 50s, while men who get it are usually in their 60s or 70s. About 80% of allthyroid cancers cases are papillary thyroid cancer. Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid. Medullary thyroid cancer starts as a growth of abnormal cancer cells within the thyroid. These special cells are the parafollicular C cells. Anaplastic thyroid cancer, also called undifferentiated thyroid cancer, is very rare and makes up only 1 to 2% of all thyroid cancers.

  • Papillary thyroid cancer
  • Follicular thyroid cancer

Track 14: Oncology Nursing

Oncology nurses care for critically or chronically ill cancer patients. They administer chemotherapy, implement new methods of symptom treatment and screen their patients' progress. Oncology nurses also create a supportive environment.

The oncology nurse able to understand pathology results and their implications and have an in-depth knowledge of the side effects of cancer treatments.

•     Taking care for people of all ages

•    Support patients

•    Handling medication

•    Administering chemotherapy

•    Direct patient care

•    Keeping the patient comfort

•    Keeping a check on diet

Track 15: Hematology-Oncology Therapy

Hematology-Oncology Therapy is a comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design permits you to instantly locate and implement the proper treatment procedure. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into three sections:

  1. Oncology
  2. Supportive Care, Drug Preparation, Complications, and Screening
  3. Selected Hematologic Diseases

Track 16: Neurological Cancer

The exact cause of brain cancer is unknown. However, factors that can increase your risk of brain cancer include exposure to high portions of ionizing radiation and a family history of brain cancer. Cancer in another part of your body is also a risk factor.

Causes and Risk Factors for Brain Cancer

  1. nausea and vomiting.
  2. headaches, which may be more intense in the morning.
  3. body weakness, such as in an arm, a leg, or the face.
  4. difficulty balancing.
  5. problems with memory.
  6. seizures

Track 17: Pediatric Hematology/Oncology:

Pediatric hematologists/oncologists analyze, treat, and manage children and teens with the following: Cancers including leukemias, lymphomas, brain tumors, bone tumors, and solid tumors. Diseases of blood cells including disorders of white cells, red cells, and platelets. Bleeding disorder

blood cancer symptoms:

  1. Fever
  2. chills
  3. Persistent fatigue
  4. weakness. Loss of appetite
  5. nausea.

Track 18: Tumor Virology and Immunology

Malignancy immunology is an interdisciplinary part of science worried about the job of the insusceptible framework in the movement and advancement of disease; the most outstanding application is disease immunotherapy, where the resistant framework is utilized to treat malignancy.

An oncolytic infection is an infection that specially taints and executes malignant growth cells. As the tainted malignancy cells are devastated by oncolysis, they discharge new irresistible infection particles or dreams to help demolish the remaining tumor.Oncolytic infections are thought not exclusively to cause direct demolition of the tumor cells, yet in addition to animate host hostile to tumor insusceptible framework reactions.

Track 19: Radiation Oncology

A radiation oncologist is a specialist doctor who uses ionizing radiation (such as megavoltage X-rays or radionuclides) in the treatment of cancer. It may also be used palliatively, to alleviate symptoms in patients with incurable cancers.

side effect of radiation treatment:

1.         fatigue (feeling tired)

2.         skin changes.

3.         Other early side effects usually are related to the area being treated, such as hair loss and mouth problems              when radiation treatment is given to this area.

4.         Late side effects can take months or even years to develop

Track 20: Clinical Oncology

Clinical oncologists are the specialists who use radiotherapy and chemotherapy to treat and manage patients with cancer. They also use a range of other treatments to treat cancers, without using surgery. 

Types of Oncologists:

    • A medical specialist treats mistreatment therapy or alternative medications, like targeted medical aid or therapy.

    • A surgical medical specialist removes the tumour and near tissue throughout surgery. He or she can also performs sure varieties of biopsies to assist diagnose cancer.

   • A radiation medical specialist treats mistreatment radiotherapy.

Other varieties of oncologists include:

    • A gynaecologic medical specialist treats gynaecologic cancers, like female internal reproductive organ, ovarian, and cervical cancers.

    • A medical specialty medical specialist treats cancer in youngsters. Some varieties of cancer occur a lot of in youngsters and teenagers. It includes sure brain tumours, leukemia, oestrogenic sarcoma, and Ewing’s malignant neoplastic disease. Varieties of cancers common in youngsters generally conjointly occur in adults. During this thing, associate degree adult could commit to work with a medical specialty medical specialist.

    • A hematologist-oncologist treats blood cancers, like leukaemia, lymphoma, and malignant neoplasm.

Role of the oncology: associate degree medical specialist manages a patient’s care throughout the course of the malady. This starts with the designation. His or her role includes:

• Explaining the cancer designation and stage

• Talking regarding all treatments and his or her most popular selection

• Delivering quality and compassionate care

• Helping patient managing the symptoms and facet effects of cancer and cancer treatment.

 


 

Market Analysis

Importance and Scope

18th World Hematology Congress 2020 accredit to extend the greatest stage for the aptitudes, explorations, experts and corporate ambassadors with its well-planned plug-in covering each moment vision about hematology and blood syndromes from the derivation causes behind blood ailments to the most best remedies in treating blood disorders and diseases this world congress is to give a revolution for innovative defense against never-ending disorders such as Thalassemia’s, lymphomas, biomarkers in blood and counter acting agents and antigen responses and to observe the immunological chattels of blood which gives acquaintance about the root origins.

Global Image Guided Surgery Devices Market

The cancer therapy market was valued at USD 125730.7 million in 2017, is expected to register a CAGR of about 8.37% during the forecast period, 2018-2023. Cancer is one of the leading causes of morbidity and mortality, globally. Cancer therapies are drugs that block the growth and proliferation of cancer by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells.

The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing for business players. Several market players are already on the lookout for better business strategies to garner a global footprint. Moreover, the players are expected to focus on get into strategic alliances in order to attract a decent consumer base across the world. The major players identified by Transparency Market Research (TMR) include Koninklijke Philips N.V., Siemens Healthineers, Analogic Corporation, GE Healthcare, Stryker, Varian Medical Systems, Inc., Brainlab AG, Medtronic,KARL STORZ GmbH & Co. KG, and Olympus Corporation. The market strategies employed by these prominent players is anticipated to be a decisive standpoint for market progress.

The hematology diagnostics marketplace was esteemed at US$ 3,167.2 million in 2017 and predictable to scope US$ 5,288.3 million by 2026 at a CAGR of 5.9% throughout the prognostication period from 2018 to 2026.

Globally hematology diagnostics marketplace scope was valued at USD 5.96 billion in 2017. It is predicted to increase at a CAGR of 5.85% over the estimate retro. Aspects such as cumulative pervasiveness of blood disorders tied with collective consciousness about these ailments, and presence of classy & cutting-edge technologies are projected to boost the market progress

The advanced investigations in the biomedical segment, exclusively in emerging countries, will boost marketplace development in flow cytometry. Aggregate of radiologists and intensifying attention on the inhibition, and primary diagnosis of ailments will drive the number of medical imaging measures like MRI and CT assessments in hospitals and ASCs across limitless countries. These are predictable to be the chief progress handlers for the global medical imaging components market.

 

Past Conference Report

World Hematology 2019

13th World Congress on Hematology and Oncology was organized October 23-24, 2019, Tokyo, Japan   with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at World Hematology 2019, a global platform to discuss various important aspects of Hematology and Oncology.

There are infinite reasons to extend our gratitude to you for making the World Hematology 2019 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve World Hematology 2019 a new heights in the field of Hematology and Oncology.

The conference was organized around the theme “Contemporary researches in Hematology and Oncology”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Hematology and Oncology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speaker Yuanchun Feng, Sichuan University, China

The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Hematology and Oncology through their fabulous presentations at the podium of World Hematology 2019.   

ConferenceSeries llc LTD offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Blood & Lymph, Journal of Blood Disorders & Transfusion and Journal of Oncology Research and Treatment who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

Your expertise and knowledge in the area of Hematology and Oncology will provide an oppor­tunity to discuss and respond to a series of questions about the status of Hematology and Oncology.

We would like to organize this conference with your support to gather all the Hematology and Oncology Researchers in a single platform hope we will be honored with your support to organize World Hematology 2019 in a grand level; your support will be the key of success for our next year conference.

We look forward to see your benign presence with active contribution and support to make this event successful once more.

Once again it’s our pleasure to welcome you to our upcoming

14th World Congress on Hematology and Oncology, September 28-29, 2020, online event/Webinar..

Let us meet again @ World Hematology 2020

 

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 28-29, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Blood Disorders & Transfusion Journal of Blood & Lymph Journal of Forensic Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner